![Steven Basta](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Steven Basta
Directeur Général chez
PHATHOM PHARMACEUTICALS, INC.
Fortune : 2 M $ au 31/05/2026
Profil
Steven L.
Basta is President, Chief Executive Officer & Director at Phathom Pharmaceuticals, Inc. since 2025.
He is Chairman at Viveve, Inc. since 2019, Chairman at Illumisonics, Inc. since 2023, Director at DermBiont, Inc. since 2020, Independent Director at VYNE Therapeutics, Inc. since 2015, and Advisor at Spindletop Capital Management LLC.
Former roles include President & Chief Executive Officer at Gliatech, Inc. from 2000 to 2002, Chief Executive Officer at BioForm Medical, Inc. from 2002 to 2010, Chief Executive Officer at Merz Aesthetics, Inc. from 2010 to 2011, Chief Executive Officer at Lifeward CA, Inc. from 2011 to 2015, Chief Executive Officer at Altergo (New York) from 2011 to 2015, Director at RF Surgical Systems, Inc. from 2013 to 2015, President, Chief Executive Officer & Director at Menlo Therapeutics, Inc. from 2015 to 2020, Chief Executive Officer at Mahana Therapeutics, Inc. from 2020 to 2022, Chairman at Viveve Medical, Inc. from 2019 to 2023, Independent Director at Carbylan Therapeutics, Inc. from 2009 to 2016, Chief Financial Officer & VP-Business Development at Creative Biomolecules, Inc. from 1997 to 2000, Associate at Dillon, Read & Co., Inc., Chief Executive Officer at SaNOtize Research & Development Corp., and Executive Director-Product Development at Orchestra Therapeutics, Inc. Education includes undergraduate studies at The Johns Hopkins University and an MBA from Kellogg School of Management.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 23/03/2026 | 254 400 ( 0,32 % ) | 2 M $ | 31/05/2026 | |
VYNE THERAPEUTICS INC 0,02 % | 12/12/2025 | 7 450 ( 0,02 % ) | 5 081 $ | 31/05/2026 |
Postes actifs de Steven Basta
| Sociétés | Poste | Début |
|---|---|---|
| VYNE THERAPEUTICS INC. | Directeur/Membre du Conseil | 01/01/2015 |
| PHATHOM PHARMACEUTICALS, INC. | Directeur Général | 01/04/2025 |
Illumisonics, Inc.
 Illumisonics, Inc. Medical DistributorsDistribution Services Develops optical imaging systems | Président | 01/11/2023 |
Spindletop Capital Management LLC
 Spindletop Capital Management LLC Investment ManagersFinance Spindletop Capital invests in companies located in the United States with an EBITDA of USD 2 –20 million and revenue of USD 15 – 100 million. The firm targets companies operating in the fields of healthcare services & distribution, biopharma & specialty pharmaceuticals, healthcare IT and medical diagnostics & devices. It provides financing for recapitalizations, MBOs, roll-ups & consolidations, corporate spin outs, secondary investments, and expansion capital requirements. It makes majority and minority investments and takes a seat on the board of directors and also makes co-investments. | Consultant / Advisor | - |
DermBiont, Inc.
 DermBiont, Inc. Miscellaneous Commercial ServicesCommercial Services Develops skin micro biome therapeutics to treat and prevent skin diseases | Directeur/Membre du Conseil | 14/03/2020 |
Viveve, Inc.
 Viveve, Inc. Medical SpecialtiesHealth Technology Develops gynecologic devices | Président | 01/01/2019 |
Anciens postes connus de Steven Basta
| Sociétés | Poste | Fin |
|---|---|---|
| VIVEVE MEDICAL, INC. | Président | 01/03/2023 |
Mahana Therapeutics, Inc.
 Mahana Therapeutics, Inc. Packaged SoftwareTechnology Services Develops digital chronic condition management programs through mobile app | Directeur Général | 01/10/2022 |
| VYNE THERAPEUTICS INC. | Directeur Général | 01/03/2020 |
| ░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░ ░░░░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Formation de Steven Basta
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
57
Relations au 1er degré
22
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 22 |
|---|---|
Creative Biomolecules, Inc.
 Creative Biomolecules, Inc. BiotechnologyHealth Technology Develops products for human tissue regeneration and organs based on morphogenic proteins | Health Technology |
Orchestra Therapeutics, Inc.
 Orchestra Therapeutics, Inc. Financial ConglomeratesFinance Operates as a development stage company | Finance |
Gliatech, Inc.
 Gliatech, Inc. BiotechnologyHealth Technology Engages in the discovery and development of bio surgery and pharmaceutical products | Health Technology |
RF Surgical Systems, Inc.
 RF Surgical Systems, Inc. Medical SpecialtiesHealth Technology Develops surgical and medical devices | Health Technology |
BioForm Medical, Inc.
 BioForm Medical, Inc. Medical SpecialtiesHealth Technology Develops technology for soft and hard tissue augmentation | Health Technology |
Carbylan Therapeutics, Inc.
 Carbylan Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of molecule protease inhibitors | Health Technology |
Viveve, Inc.
Viveve, Inc. Medical SpecialtiesHealth Technology Develops gynecologic devices | Health Technology |
Lifeward CA, Inc.
 Lifeward CA, Inc. Medical/Nursing ServicesHealth Services Provides physical rehabilitation and training services | Health Services |
Menlo Therapeutics, Inc.
 Menlo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of serlopitant products | Health Technology |
Dillon, Read & Co., Inc.
 Dillon, Read & Co., Inc. Investment Banks/BrokersFinance Provides brokerage services | Finance |
The Johns Hopkins University
 The Johns Hopkins University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Merz Aesthetics, Inc.
 Merz Aesthetics, Inc. Medical SpecialtiesHealth Technology Develops technology for soft and hard tissue augmentation | Health Technology |
Spindletop Capital Management LLC
Spindletop Capital Management LLC Investment ManagersFinance Spindletop Capital invests in companies located in the United States with an EBITDA of USD 2 –20 million and revenue of USD 15 – 100 million. The firm targets companies operating in the fields of healthcare services & distribution, biopharma & specialty pharmaceuticals, healthcare IT and medical diagnostics & devices. It provides financing for recapitalizations, MBOs, roll-ups & consolidations, corporate spin outs, secondary investments, and expansion capital requirements. It makes majority and minority investments and takes a seat on the board of directors and also makes co-investments. | Finance |
Kellogg School of Management
 Kellogg School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Viveve Medical, Inc.
 Viveve Medical, Inc. Medical SpecialtiesHealth Technology Designs, develops, manufactures and markets a platform medical technology | Health Technology |
DermBiont, Inc.
DermBiont, Inc. Miscellaneous Commercial ServicesCommercial Services Develops skin micro biome therapeutics to treat and prevent skin diseases | Commercial Services |
Mahana Therapeutics, Inc.
Mahana Therapeutics, Inc. Packaged SoftwareTechnology Services Develops digital chronic condition management programs through mobile app | Technology Services |
Ion Energy, Inc.
 Ion Energy, Inc. Electrical ProductsProducer Manufacturing Manufactures lithium ion batteries for vehicles | Producer Manufacturing |
Phathom Pharmaceuticals, Inc.
 Phathom Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel treatments for gastrointestinal diseases and disorders | Health Technology |
SaNOtize Research & Development Corp.
 SaNOtize Research & Development Corp. Miscellaneous Commercial ServicesCommercial Services Develops antimicrobial and immunomodulation technology to treat and prevent microbial infections, including drug resistant microbes | Commercial Services |
VYNE Therapeutics, Inc.
 VYNE Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Illumisonics, Inc.
Illumisonics, Inc. Medical DistributorsDistribution Services Develops optical imaging systems | Distribution Services |
